0001225208-24-002963.txt : 20240226
0001225208-24-002963.hdr.sgml : 20240226
20240226175221
ACCESSION NUMBER: 0001225208-24-002963
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240223
FILED AS OF DATE: 20240226
DATE AS OF CHANGE: 20240226
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GALLAHUE KIERAN
CENTRAL INDEX KEY: 0001308428
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15525
FILM NUMBER: 24680710
MAIL ADDRESS:
STREET 1: PO BOX 684369
CITY: PARK CITY
STATE: UT
ZIP: 84068
FORMER NAME:
FORMER CONFORMED NAME: Gallahue Kieran
DATE OF NAME CHANGE: 20041110
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Edwards Lifesciences Corp
CENTRAL INDEX KEY: 0001099800
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 364316614
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE EDWARDS WAY
CITY: IRVINE
STATE: CA
ZIP: 92614
BUSINESS PHONE: 9492502500
MAIL ADDRESS:
STREET 1: ONE EDWARDS WAY
CITY: IRVINE
STATE: CA
ZIP: 92614
FORMER COMPANY:
FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP.
DATE OF NAME CHANGE: 20090225
FORMER COMPANY:
FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP
DATE OF NAME CHANGE: 20000203
FORMER COMPANY:
FORMER CONFORMED NAME: CVG CONTROLLED INC
DATE OF NAME CHANGE: 19991126
4
1
doc4.xml
X0508
4
2024-02-23
0001099800
Edwards Lifesciences Corp
EW
0001308428
GALLAHUE KIERAN
ONE EDWARDS WAY
IRVINE
CA
92614
1
0
Common Stock
2024-02-23
4
M
0
7056.0000
36.8633
A
10757.0000
D
Common Stock
2024-02-23
4
G
0
7056.0000
0.0000
D
3701.0000
D
Common Stock
2024-02-23
4
G
0
7056.0000
0.0000
A
70277.0000
I
By Trust
Common Stock
2024-02-23
4
S
0
3058.0000
87.6100
D
67219.0000
I
By Trust
Director Stock Option (Right to Acquire)
36.8633
2024-02-23
4
M
0
7056.0000
0.0000
D
2017-05-12
2024-05-11
Common Stock
7056.0000
0.0000
D
This transaction was executed in multiple trades at prices ranging from $87.5908 to $87.6210. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.
Linda J. Park, Attorney-in-Fact
2024-02-26